Sort
16,179 grants matching “malaria”
Genomic Sequencing to Establish a Macaque Genotype and Phenotype Research Resource
$879,197Betsy M Ferguson · Oregon Health & Science University · R24 · FY2016 · OD
Impact of Immunotherapy on Viral Immunity in Humans
$879,190Raymond T Chung · Massachusetts General Hospital · U19 · FY2021 · AI
Structure and function of eukaryotic DNA transposases
$878,398Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
$878,071Elliott Paul Dawson · Bioventures, Inc. · R42 · FY2017 · HG
Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomicsâ reduced genome E. coli strains
$877,755Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2017 · AI
Comparing Community and Facility Management of Malaria and Pneumonia in Tanzania
$877,453Salim Mohammed Khamis Abdulla · Ifakara Health Institute · U01 · FY2006 · CI
KSHV Infection And Persistence
$877,104Kenneth M Kaye · Brigham And Women'S Hospital · R01 · FY2025 · AI
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
$875,813Satish Gopal · Univ Of North Carolina Chapel Hill · U54 · FY2017 · CA
Malaria Drug Resistance and Disease Virulence
$874,777Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Parasite-Derived Vesicles in Babesia virulence and Vaccine Development
$874,372Choukri Ben Mamoun · Yale University · R56 · FY2024 · AI
Surveillance and research for the innovation and sustainability of public health actions
$874,000Celia Cordon-Rosales · University Of The Valley Of Guatemala · U01 · FY2022 · GH
Safe Pregnancy by Infectious Disease Control in Kinshasa
$873,636Carl Bose · Univ Of North Carolina Chapel Hill · U01 · FY2006 · HD
A user-friendly point-of-care device for G6PDH determination
$873,090Robert Harper · Analytical Diagnostic Solutions, Inc. · R44 · FY2019 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Service Core
$871,800Peter Skene · Seattle Children'S Hospital · U19 · FY2024 · AI
Safety and efficacy of PfSPZ malaria vaccine in malaria-exposed adults
$870,936Christopher V. Plowe · University Of Maryland Baltimore · U01 · FY2017 · AI
Once Bitten: Acquisition of Malaria Adaptive Immunity (OBAMA - Immunity)
$870,556Wendy Prudhommeomeara · Duke University · R01 · FY2023 · AI
Function of granulysin
$870,505Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Regulation of RANTES expression in T lymphocytes
$870,505Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Preclinical Development of PS-26 - an Oxybiguanide
$870,251Jacobus Pharmaceutical Company, Inc. · R44 · FY2002 · AI
Novel Anti-Malarials by Combinatorial Pharmacogenomics
$869,971University Of California San Francisco · U01 · FY2002 · AI
Data Management and Biostatistics Core
$869,816Alfred Matengeni · Michigan State University · U19 · FY2022 · AI
MALARIA EPIDEMIOLOGY AND ENTOMOLOGY IN MALI
$869,430National School Of Medicine And Pharmacy · P50 · FY2000 · AI
Elucidating the role of TSR glycosylation in Plasmodium parasites
$868,274Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2020 · AI
BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES
$867,371David S. Roos · University Of Pennsylvania · N01 · FY2018 · AI
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal
$867,208Matthew G Dorsey · University Of California, San Francisco · U19 · FY2024 · AI